**** Iron Overload News is a current news service provided by Doctor's Guide®. Novartis accepts no responsibility for and makes no representations or warranties regarding the content of the information presented. ****

Week of 12 October 2008
• Derivation of a risk assessment tool for emergency department patients with sickle cell disease
Week of 5 October 2008
• Ankylosing spondylitis in a patient with myelodysplastic syndrome: an association with HLA-B27 or coincidence?
• Demethylating agents in myeloid malignancies
• Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome
• Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
Week of 28 September 2008
• Single agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13
• Deferasirox Treatment Improved the Hemoglobin Level and Decreased Transfusion Requirements in Four Patients with the Myelodysplastic Syndrome and Primary Myelofibrosis
• Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome
• Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells
• Sibling history of asthma is a risk factor for pain in children with sickle cell anemia
Week of 21 September 2008
• Hematopoietic stem cell transplantation in thalassemia
• Aberrant increase in the immature platelet fraction in patients with myelodysplastic syndrome: a marker of karyotypic abnormalities associated with poor prognosis
• Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years
Week of 14 September 2008
• Bilateral profound sudden sensorineural hearing loss presenting a diagnostic conundrum in a child with sickle cell anaemia
• A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome
• New recurrent deletions in the PPARgamma and TP53 genes are associated with childhood myelodysplastic syndrome
• Pattern of trisomy 1q in hematological malignancies: a single institution experience


The staff of medical writers at Doctor's Guide® may independently summarize and abstract the most current articles on subjects in oncology from the major peer-reviewed medical publications, such as JAMA, New England Journal of Medicine. In all cases, Doctor's Guide® cites the original sources of it's material.

Learn about the benefits of chelation therapy.